22.11
1.73%
-0.39
Fulgent Genetics Inc Borsa (FLGT) Ultime notizie
Russell Investments Group Ltd. Sells 17133 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Defense World
Moffitt Cancer Center and Fulgent Pharma form a strategic partnership - Tampa Bay Business & Wealth - TBBW
TBBW
Moffitt and Fulgent Pharma partner on personalised cancer therapies - Yahoo Finance
Yahoo Finance
Moffitt and Fulgent partner on personalised cancer therapies - Pharmaceutical Technology
Pharmaceutical Technology
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics - Business Wire
Business Wire
Is Fulgent Genetics (FLGT) Outperforming Other Medical Stocks This Year? - Yahoo Movies Canada
Yahoo Movies Canada
Trading (FLGT) With Integrated Risk Controls - Stock Traders Daily
Stock Traders Daily
Shareholders May Be Wary Of Increasing Fulgent Genetics, Inc.'s (NASDAQ:FLGT) CEO Compensation Package - Simply Wall St
Simply Wall St
UBS analysts initates a Neutral rating for Fulgent Genetics Inc (FLGT) – Knox Daily - Knox Daily
Knox Daily
Zurcher Kantonalbank Zurich Cantonalbank Increases Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Defense World
Analysts Have Been Trimming Their Fulgent Genetics, Inc. (NASDAQ:FLGT) Price Target After Its Latest Report - Simply Wall St
Simply Wall St
Fulgent Genetics, Inc. (FLGT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Canada Shine On
Yahoo Canada Shine On
Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St
Simply Wall St
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Earnings call: Fulgent Genetics sees Q1 growth, targets higher margins - Investing.com Canada
Investing.com Canada
Earnings call: Fulgent Genetics sees Q1 growth, targets higher margins - Investing.com
Investing.com
Earnings call: Fulgent Genetics sees Q1 growth, targets higher margins - Investing.com India
Investing.com India
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
Fulgent Genetics Inc (FLGT) Q1 2024 Earnings: Misses Analyst Forecasts with Wider Losses - GuruFocus.com
GuruFocus.com
Fulgent Genetics Releases Updated Investor Presentation - TipRanks.com - TipRanks
TipRanks
Fulgent Reports First Quarter 2024 Financial Results - Yahoo Finance
Yahoo Finance
Fulgent Genetics (NASDAQ:FLGT) Releases FY 2024 Earnings Guidance - MarketBeat
MarketBeat
American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024 - Business Wire
Business Wire
Fulgent Genetics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Yahoo Finance
Fulgent Genetics Shares Business Insights in Investor Update - TipRanks.com - TipRanks
TipRanks
Privia Health (PRVA) Misses Q4 Earnings Estimates
Zacks Investment Research
Health Catalyst (HCAT) Q4 Earnings and Revenues Beat Estimates
Zacks Investment Research
Fulgent Genetics Stock: Buy Growth Ahead Below Liquidation Value (NASDAQ:FLGT) - Seeking Alpha
Seeking Alpha
Cooper Companies (COO), Fulgent Unite to Boost Genetic Testing - Yahoo Finance
Yahoo Finance
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing - PR Newswire
PR Newswire
The 3 Best Digital Health Stocks for Personalized Medicine - InvestorPlace
InvestorPlace
Fulgent Genetics Inc (FLGT) Reports Q3 2023 Financial Results - Yahoo Finance
Yahoo Finance
Fulgent Genetics, Inc. (NASDAQ:FLGT) is definitely on the radar of institutional investors who own 47% of the company - Yahoo Finance
Yahoo Finance
Fulgent Moves Beyond Covid - Los Angeles Business Journal
Los Angeles Business Journal
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist - The Motley Fool
The Motley Fool
LA500 2023: Ming Hsieh - Los Angeles Business Journal
Los Angeles Business Journal
Fulgent Genetics Launches Mission Bio Platform to Broaden Accessibility of Single-Cell Multi-Omics for Drug ... - PR Newswire
PR Newswire
Global Carrier Screening Market to 2031: Players Include Fulgent Genetics, Illumina, Diasorin, Natera and Thermo ... - GlobeNewswire
GlobeNewswire
Fulgent Genetics Launches New Beacon787 Expanded Carrier Screening Panel - Business Wire
Business Wire
Fulgent Genetics facing class-action lawsuit after DOJ investigation - 2UrbanGirls
2UrbanGirls
Fulgent Genetics Now Being Investigated by DOJ - 209 Times
209 Times
Top 5 Best Genomics Stocks to Watch 2024 - Admiral Markets
Admiral Markets
Company files objection to mediation in Medicare fraud case - New Castle News
New Castle News
1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings - The Motley Fool
The Motley Fool
Fulgent Makes Post-Covid Acquisition - Los Angeles Business Journal
Los Angeles Business Journal
Fulgent Genetics acquires therapeutics development firm Fulgent Pharma - Pharmaceutical Technology
Pharmaceutical Technology
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company - Business Wire
Business Wire
Fulgent Genetics, Inc. Facing Class Action on Behalf of Investors Following Department of Justice Investigation into ... - PR Newswire
PR Newswire
Fulgent Share Price Tumbles as Covid Test Revenue Tails Off - Los Angeles Business Journal
Los Angeles Business Journal
Capitalizzazione:
|
Volume (24 ore):